Endolymphatic Sac Tumours (ELST)

Endolymphatic sac tumours (ELST) is a very rare group tumour that develops in the endolymphatic sac, which is a balloon shaped structure in the inner ear. These tumours are often classified as benign, however they can become malignant.

The endolymphatic sac and duct are filled with fluid that surrounds and protects other structures in the inner ear, which affect hearing and balance. They are responsible for releasing fluid to regulate pressure and volume in the inner ear, removing excess fluid and waste products from the inner ear, and regulating the immune response in the inner ear.

ELSTs are often associated with Von Hippel-Lindau (VHL) syndrome, which is a rare genetic disorder that causes the development of multiple benign and malignant tumours throughout the body.

ELSTs are often diagnosed equally between the sexes, and are often diagnosed around 30 years of age. However, anyone can develop this disease.

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, as ELSTs are considered benign, these tumours are generally considered low-grade and not staged.

Once your tumour has been diagnosed, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment is dependent on several factors, including tumour size, age, stage of disease and overall health.

Treatment options for ELSTs may include:

  • Surgery, potentially including:
    • Mastoidectomy.
    • Lateral temporal bone resection (LTBR).
    • Nerve repair surgery.
  • Radiation therapy.
  • Clinical trials.
  • Palliative care.

Risk factors

Because of how rare ELSTs are, there has been limited research done into the risk factors of this disease. However, there has been a definitive link between the development of ELSTs and patients who have been diagnosed with VHL.

Symptoms

ELSTs may appear asymptomatic in the early stages of disease. As the tumour progresses (often rapidly), some of the following symptoms may appear:

  • Hearing loss.
  • Tinnitus.
  • Dizziness.
  • A feeling of pressure in the ear.
  • Facial paralysis (rare).

Patients with VHL may experience additional symptoms depending on the tumours present.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have an ELST, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Neurological examination.
  • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
  • Blood tests.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.